Insmed Inc. buy Royal Bank of Canada
Start price
11.06.25
/
50%
€86.50
Target price
11.06.26
€92.91
Performance (%)
41.90%
Price
17.04.26
€120.36
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Insmed Inc. has seen massive gains of 41.90%. This prediction currently runs until 11.06.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -8.290% | -8.290% |
| iShares Core DAX® | 3,59 % | 3,93 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % |
| iShares S&P 500 | 4,14 % | 4,04 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Royal Bank of Canada from $99.00 to $106.00. They now have an "outperform" rating on the stock.
Ratings data for INSM provided by MarketBeat